A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting 27 enrolled Institute of Hematology & Blood Diseases Hospital, China

NaSingle-groupOpen-labelTreatment

Summary

A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1194C CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell NonHodgkin Lymphoma.

Timeline

Start: 2025-07-15
Primary completion: 2026-06-30
Completion: 2027-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CT1194C	Cell therapy	—	—

A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Summary

Timeline

Drugs

Indications